Sendero Bio is a biotechnology company formed through a partnership with Mayo Clinic to develop novel oncology therapies.

The company has licensed technology from Dr. Andrew Badley's lab to advance therapies against TRAILshort, a newly discovered immune evasion target of the TRAIL pathway.

---

For more information, contact us at
info@senderobio.com